High prevalence of tuberculosis infection in HIV-1 exposed kenyan infants

Pediatric Infectious Disease Journal

Volumn 33, Issue 4, 2014, Pages 401-406

  Cranmer, Lisa M ^a,b   Kanyugo, Mercy ^c   Jonnalagadda, Sasi R ^d   Lohman Payne, Barbara ^d   Sorensen, Bess ^d   Maleche Obimbo, Elizabeth ^c   Wamalwa, Dalton ^c   John Stewart, Grace C ^a,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

HIV 1 exposure; Infant; Interferon gamma release assay; T SPOT.TB; Tuberculosis

Indexed keywords

BCG VACCINE; ZIDOVUDINE;

ADULT; ARTICLE; BCG VACCINATION; CHILD; CRYOPRESERVATION; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FEVER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; INFANT DISEASE; INFECTION PREVENTION; INTERFERON GAMMA RELEASE ASSAY; KENYA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MOTHER; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TUBERCULIN TEST; BLOOD; COHORT ANALYSIS; HIV INFECTIONS; MICROBIOLOGY; MONONUCLEAR CELL; STATISTICS AND NUMERICAL DATA; TUBERCULOSIS; VIROLOGY; YOUNG ADULT;

ADULT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INTERFERON-GAMMA RELEASE TESTS; KENYA; LEUKOCYTES, MONONUCLEAR; MATERNAL EXPOSURE; MOTHERS; TUBERCULOSIS; YOUNG ADULT;

EID: 84897028959     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000124     Document Type: Article

References (27)

1. Swaminathan S, Rekha B. Pediatric tuberculosis: Global overview and challenges. Clin Infect Dis. 2010;50(suppl 3):S184-S194.
2. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intrathoracic tuberculosis: A critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8:392-402.
3. Van Rie A, Madhi SA, Heera JR, et al. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol. 2006;13:246-252.
4. Miles DJ, Gadama L, Gumbi A, et al. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guérin (BCG) vaccine in HIVuninfected infants. Immunology. 2010;129:446-454.
5. Cotton MF, Schaaf HS, Lottering G, et al.; PACTG 1041 Team. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis. 2008;12:225-227.
6. Wood R, Liang H, Wu H, et al. Changing prevalence of tuberculosis infection with increasing age in high-burden townships in South Africa. Int J Tuberc Lung Dis. 2010;14:406-412.
7. Shanaube K, Sismanidis C, Ayles H, et al. Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa. PLoS One. 2009;4:e7749.
8. Burl S, Adetifa UJ, Cox M, et al. The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-Tuberculosis mycobacteria (NTM) during early life. PLoS One. 2010;5:e12287.
9. Jonnalagadda S, Lohman Payne B, Brown E, et al. Latent tuberculosis detection by interferon γ release assay during pregnancy predicts active tuberculosis and mortality in human immunodeficiency virus type 1-infected women and their children. J Infect Dis. 2010;202: 1826-1835.
10. Division of Leprosy Tuberculosis and Lung Disease MoPHaS, Kenya. National NLTP guideline: What the health care worker needs to know. Ministry of Public Health and Sanitation Division of Leprosy, Tuberculosis and Lung Disease. August 2005. Available at: Http://wwwnltpcoke/docs/ National-NLTP-Guidelinepdf. Accessed December 14, 2012.
11. Panteleeff DD, John G, Nduati R, et al. Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol. 1999;37:350-353.
12. Graham SM, Ahmed T, Amanullah F, et al. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis. 2012;205(suppl 2):S199-S208.
13. Marais BJ, Obihara CC, Gie RP, et al. The prevalence of symptoms associated with pulmonary tuberculosis in randomly selected children from a high burden community. Arch Dis Child. 2005;90:1166-1170.
14. Marais BJ, Gie RP, Obihara CC, et al. Well defined symptoms are of value in the diagnosis of childhood pulmonary tuberculosis. Arch Dis Child. 2005;90:1162-1165.
15. Wallgren A. The time-Table of tuberculosis. Tubercle. 1948;29:245-251.
16. World Health Organization. Provisional guidelines for the diagnosis and classification of the EPI target diseases for primary health care, suveillance, and special studies. EPI/GEN/83/4. Geneva, Switzerland; 1983.
17. Cain KP, McCarthy KD, Heilig CM, et al. An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med. 2010;362: 707-716.
18. Beattie T, Kaul R, Rostron T, et al. Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes. AIDS. 2004;18:1595-1598.
19. Rieder H. Annual risk of infection with Mycobacterium tuberculosis. Eur Respir J. 2005;25:181-185.
20. Slyker JA, Lohman-Payne B, John-Stewart GC, et al. The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life. Front Immunol. 2012;3:399.
21. Madhi SA, Nachman S, Violari A, et al.; P1041 Study Team. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med. 2011;365:21-31.
22. Mandalakas AM, Kirchner HL, Lombard C, et al. Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection. Int J Tuberc Lung Dis. 2012;16:1033-1039.
23. Nachman S, Zeldow, B, Dittmer, S, et al. Lack of Identification of Adult TB Contacts in Infants with Microbiologically Confirmed or Clinically presumed TB (MCCP TB) in Clinical Trial P1041. In: 6th International AIDS Society Conference on HIV Pathogenesis and Treatment; Abstract no. WEPDB0201; Rome, Italy; 2011.
24. Zar HJ, Cotton MF, Strauss S, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: Randomised controlled trial. BMJ. 2007;334:136.
25. World Health Organization. Use of tuberculosis interferon-gamma release assays (IGRAs) in low-And middle-income countries: Policy statement. Geneva, Switzerland: WHO Press; 2011.
26. Smith SG, Joosten SA, Verscheure V, et al. Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from Mycobacterium tuberculosis. PLoS One. 2009;4:e7972.
27. Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-γ release assays for incident active tuberculosis: A systematic review and meta-Analysis. Lancet Infect Dis. 2012;12:45-55.